<p>Rate of virological success (<400 copies/ml) at 12 months–intention to treat analysis.</p
<p>Cumulative probability of virologic failure after 6 months of ART by regimen.</p
<p>* Over the first year after therapy, the serological cure rate increased over the first 6 months;...
<p>Proportion of patients with HIV-1 RNA < 50 copies/mL (ITT FDA snapshot analysis) at weeks 48, 96 ...
<p>Proportion of Patients with Virologic Suppression (≤400 copies/mL), by Age Group and Weeks from c...
<p>Time trend of the proportion of patients with incomplete virological suppression (defined as havi...
<p>Cumulated proportion of success over the 12 weeks of the outbreak (n = 1,000 simulations).</p
Analysis of number of days from antiretroviral therapy initiation to achieving suppressed viral load...
Proportion of responders with HIV-1 RNA <40 copies/mL (Week 24 snapshot) (mITT).</p
<p>Virological response rates at EOT, FU12 and FU24 in the ITT, mITT and completer population.</p
<p>Percentage of children achieving viral suppression after 6 months of ART, by travel time.</p
<p>A) median CD4+ cell count (cells/mm<sup>3</sup>) over time on ART; and, B) percentage of patients...
<p>Unadjusted Kaplan-Meier curves for A) Rates of CD4 recovery of 150 cells/mm<sup>3</sup> by 12 mon...
<p>Legend: A) time spent on HAART to achieve a HIV-1 RNA (VL) ≤400, copies/mL; B) time spent on HAAR...
<p>The sustained virologic response (SVR) 12 rates of the IFN-free treatment-naïve patients and IFN-...
<p>The proportion of patients with a detectable viral load (≥400 copies/ml) at study visits using th...
<p>Cumulative probability of virologic failure after 6 months of ART by regimen.</p
<p>* Over the first year after therapy, the serological cure rate increased over the first 6 months;...
<p>Proportion of patients with HIV-1 RNA < 50 copies/mL (ITT FDA snapshot analysis) at weeks 48, 96 ...
<p>Proportion of Patients with Virologic Suppression (≤400 copies/mL), by Age Group and Weeks from c...
<p>Time trend of the proportion of patients with incomplete virological suppression (defined as havi...
<p>Cumulated proportion of success over the 12 weeks of the outbreak (n = 1,000 simulations).</p
Analysis of number of days from antiretroviral therapy initiation to achieving suppressed viral load...
Proportion of responders with HIV-1 RNA <40 copies/mL (Week 24 snapshot) (mITT).</p
<p>Virological response rates at EOT, FU12 and FU24 in the ITT, mITT and completer population.</p
<p>Percentage of children achieving viral suppression after 6 months of ART, by travel time.</p
<p>A) median CD4+ cell count (cells/mm<sup>3</sup>) over time on ART; and, B) percentage of patients...
<p>Unadjusted Kaplan-Meier curves for A) Rates of CD4 recovery of 150 cells/mm<sup>3</sup> by 12 mon...
<p>Legend: A) time spent on HAART to achieve a HIV-1 RNA (VL) ≤400, copies/mL; B) time spent on HAAR...
<p>The sustained virologic response (SVR) 12 rates of the IFN-free treatment-naïve patients and IFN-...
<p>The proportion of patients with a detectable viral load (≥400 copies/ml) at study visits using th...
<p>Cumulative probability of virologic failure after 6 months of ART by regimen.</p
<p>* Over the first year after therapy, the serological cure rate increased over the first 6 months;...
<p>Proportion of patients with HIV-1 RNA < 50 copies/mL (ITT FDA snapshot analysis) at weeks 48, 96 ...
DOI
Add to ORKG